Applying targeted long-read sequencing to assess an expanded repeat in C9orf72

Presented at: CRISPR 2020
C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Assistant Professor of Neuroscience, Mayo Clinic
    Biography

      Dr. Marka van Blitterswijk is an Assistant Professor and Associate Consultant in the Department of Neuroscience at Mayo Clinic. She obtained her MS degree in Bioinformatics at Johns Hopkins University (Baltimore, MD). Dr. Van Blitterswijk completed her MD and PhD degree at Utrecht University (the Netherlands). Her laboratory at Mayo Clinic focuses on the discovery of novel genes, disease modifiers, therapeutic targets, and biomarkers for neurodegenerative diseases. She is particularly interested in the most frequent genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD): a C9orf72 repeat expansion. Her laboratory employs innovative patient-oriented strategies. As a geneticist and bioinformatician, she has broad experience using various genomic technologies and analyses, such as long-read sequencing and machine learning.


    Abstract

    A repeat expansion in the C9orf72-SMCR8 complex subunit (C9orf72) represents the most common genetic cause of two fatal neurodegenerative diseases: frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). To determine the length of this repeat expansion, we used No-Amp sequencing (Pacific Biosciences [PacBio]), a targeted amplification-free long-read sequencing technology. In total, we examined 28 fully characterized C9orf72 expansion carriers for whom cerebellar tissue was available. We obtained more than 3500 circular consensus sequencing (CCS) reads, including 814 reads that spanned the C9orf72 repeat expansion. Repeat lengths obtained using No-Amp sequencing significantly correlated with those obtained using Southern blotting. Importantly, we demonstrated that smaller expansions are associated with prolonged survival after onset. Moreover, we revealed that smaller expansions associate with higher levels of transcripts containing the expansion and of dipeptide repeat (DPR) proteins, a hallmark of C9orf72-linked diseases. These findings suggest that, during transcription, it might be easier to cover small expansions than long expansions, which could explain why we observed elevated levels of expansion-containing transcripts in patients with smaller expansions. Since these expansion-containing transcripts can serve as templates for repeat-associated non-ATG (RAN) translation, this could account for the increased levels of DPR proteins we detected. Investigation of the expansion itself uncovered that its GC-content is high (100%). The expansion appears to be relatively pure, while interruptions are only occasionally encountered (<5%). In conclusion, we have shown that No-Amp sequencing is a powerful tool to examine the length and purity of repeat expansions, which enabled us to identify relevant clinico-pathological associations for C9orf72-related diseases.

    Learning Objectives:

    1. Learn about methods that can be employed to detect and size C9orf72 repeat expansions

    2. Understand that targeted long-read sequencing accurately measures the C9orf72 repeat length and presence of interruptions


    Show Resources
    You May Also Like
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    NOV 16, 2020 8:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    NOV 10, 2020 7:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    NOV 10, 2020 7:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: November 10, 2020 TIME: 7:00am PDT, 10:00am EDT Automation can provide tremendous benefits such as increased pipetting precision and accuracy, productivity, and throughput. Numerous wo...
    OCT 29, 2020 6:00 AM PDT
    C.E. CREDITS
    OCT 29, 2020 6:00 AM PDT
    Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
    MAY 08, 2020 10:00 AM PDT
    C.E. CREDITS
    MAY 08, 2020 10:00 AM PDT
    DATE: May 8, 2020 TIME: 10:00am PT, 11:00am MT, 1:00pm ET The application of next generation sequencing to interrogate immune repertoires and methods in which these highly complex dataset...
    NOV 18, 2020 8:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    Loading Comments...
    Show Resources